These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9877185)

  • 1. The changing face of rheumatic fever in the 20th century.
    Stollerman GH
    J Med Microbiol; 1998 Aug; 47(8):655-7. PubMed ID: 9877185
    [No Abstract]   [Full Text] [Related]  

  • 2. Changing epidemiology of acute rheumatic fever in the United States.
    Lee GM; Wessels MR
    Clin Infect Dis; 2006 Feb; 42(4):448-50. PubMed ID: 16421786
    [No Abstract]   [Full Text] [Related]  

  • 3. Changing streptococci and prospects for the global eradication of rheumatic fever.
    Stollerman GH
    Perspect Biol Med; 1997; 40(2):165-89. PubMed ID: 9058950
    [No Abstract]   [Full Text] [Related]  

  • 4. Temporal changes in streptococcal M protein types and the near-disappearance of acute rheumatic fever in the United States.
    Shulman ST; Stollerman G; Beall B; Dale JB; Tanz RR
    Clin Infect Dis; 2006 Feb; 42(4):441-7. PubMed ID: 16421785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group A streptococci: pathogenesis and immunity.
    Maxted WR
    Soc Appl Bacteriol Symp Ser; 1978; 7():107-25. PubMed ID: 364656
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular heterogeneity among north Indian isolates of Group A Streptococcus.
    Sagar V; Bakshi DK; Nandi S; Ganguly NK; Kumar R; Chakraborti A
    Lett Appl Microbiol; 2004; 39(1):84-8. PubMed ID: 15189292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptococcal M protein.
    Fischetti VA
    Sci Am; 1991 Jun; 264(6):58-65. PubMed ID: 1857955
    [No Abstract]   [Full Text] [Related]  

  • 8. Pioneers and modern ideas. Rheumatic fever--a half-century perspective.
    Markowitz M
    Pediatrics; 1998 Jul; 102(1 Pt 3):272-4; discussion 288-9. PubMed ID: 9719793
    [No Abstract]   [Full Text] [Related]  

  • 9. Strain prevalence, rather than innate virulence potential, is the major factor responsible for an increase in serious group A streptococcus infections.
    Rogers S; Commons R; Danchin MH; Selvaraj G; Kelpie L; Curtis N; Robins-Browne R; Carapetis JR
    J Infect Dis; 2007 Jun; 195(11):1625-33. PubMed ID: 17471432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future streptococcal M. vaccine against rheumatic fever.
    Imran M; Jan A
    J Pak Med Assoc; 1988 Jul; 38(7):176-7. PubMed ID: 3149682
    [No Abstract]   [Full Text] [Related]  

  • 11. Rheumatic fever in the United States: no longer a disease of the past.
    Kaplan EL; Markowitz M
    N Z Med J; 1988 Jun; 101(847 Pt 2):402-4. PubMed ID: 3045714
    [No Abstract]   [Full Text] [Related]  

  • 12. The rheumatogenic and nephritogenic strains of the group A streptococcus: the Kuwait experience.
    Majeed HA; Khuffash FA; Yousof AM; Farwana SS; Chugh TD; Rotta J; Havlickpva H
    N Z Med J; 1988 Jun; 101(847 Pt 2):398-401. PubMed ID: 3045712
    [No Abstract]   [Full Text] [Related]  

  • 13. High pharyngeal carriage rates of Streptococcus pyogenes in Dunedin school children with a low incidence of rheumatic fever.
    Dierksen KP; Inglis M; Tagg JR
    N Z Med J; 2000 Nov; 113(1122):496-9. PubMed ID: 11198543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of rheumatic fever: a review.
    Rotta J
    Ann Trop Paediatr; 1983 Mar; 3(1):1-8. PubMed ID: 6191642
    [No Abstract]   [Full Text] [Related]  

  • 15. Streptococcus pyogenes emm types and subtypes of isolates from paediatric asymptomatic carriers and children with pharyngitis.
    Blandino G; Puglisi S; Speciale A; Musumeci R
    New Microbiol; 2011 Jan; 34(1):101-4. PubMed ID: 21344154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New aspects of the etiology and pathogenesis of rheumatic fever].
    Rotta J
    Revmatologiia (Mosk); 1984; (1):62-6. PubMed ID: 6372012
    [No Abstract]   [Full Text] [Related]  

  • 17. Don't forget about Streptococcus pyogenes! (comment on Microbes Infect. 5 (2003) 1329-1335).
    Collin M
    Microbes Infect; 2004 Mar; 6(3):336; author reply 337. PubMed ID: 15026018
    [No Abstract]   [Full Text] [Related]  

  • 18. Streptococcal pharyngitis and rheumatic heart disease: the superantigen hypothesis revisited.
    Hurst JR; Kasper KJ; Sule AN; McCormick JK
    Infect Genet Evol; 2018 Jul; 61():160-175. PubMed ID: 29530660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of streptococcal inhibitor of complement variants in pharyngitis and invasive isolates in an epidemic of serotype M1 group A Streptococcus infection.
    Hoe NP; Vuopio-Varkila J; Vaara M; Grigsby D; De Lorenzo D; Fu YX; Dou SJ; Pan X; Nakashima K; Musser JM
    J Infect Dis; 2001 Feb; 183(4):633-9. PubMed ID: 11170990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactivity between streptococcus and human tissue: a model of molecular mimicry and autoimmunity.
    Froude J; Gibofsky A; Buskirk DR; Khanna A; Zabriskie JB
    Curr Top Microbiol Immunol; 1989; 145():5-26. PubMed ID: 2680297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.